Edesa Biotech, Inc. (EDSA) — research page
US · us-cm-kg/NASDAQ/EDSA · as of 2026-11-08
Identity and listing
The issuer is Edesa Biotech, Inc., listed on NASDAQ under ticker EDSA, ISIN US27966L3069. The LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-A1). The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is British Columbia, Canada. The segment is not on the record. The listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Edesa Biotech, Inc. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | EDSA | source · 2026-11-08 |
| ISIN | US27966L3069 | source · 2026-10-14 |
| LEI | not on the record | |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | British Columbia, Canada | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 74 filings across 41 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 30 directors' dealings, 20 regulatory filings, 8 results, 6 corporate news, 5 prospectuses, 3 director changes and 2 AGM/EGM filings. The median gap between filing days is 6.0 days, the same as the exchange median of 6.0 days and the sector median of 6.0 days. The latest filing is dated 2026-11-05 and is of type directors' dealings, 3 days before the record date. The exchange median latency is 5.0 days and the sector median latency is 4.0 days. The exchange median filings in the window is 52 and the sector median is 63.0.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 74 | 6 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | directors_dealings | 4 | 4 |
| 2026-11-04 | regulatory_filing | SCHEDULE 13G/A | SCHEDULE 13G/A |
| 2026-10-29 | directors_dealings | 4 | 4 |
| 2026-10-23 | director_change | 8-K | 8-K — FORM 8-K (items 5.02) |
| 2026-10-15 | corporate_news | 8-K | 8-K — FORM 8-K (items 8.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is MNP LLP, located in Toronto, Canada. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change events. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names four research houses: Brookline Capital Markets, H.C. Wainwright, Lucid Capital Markets and Zacks Small-Cap Research.
| research house | analyst | source · read date |
|---|---|---|
| Brookline Capital Markets | Kumar Raja, PhD | issuer page · 2026-11-11 |
| H.C. Wainwright | Yi Chen, PhD, CFA | issuer page · 2026-11-11 |
| Lucid Capital Markets | Dev Prasad, PhD, MBA | issuer page · 2026-11-11 |
| Zacks Small-Cap Research | David Bautz, PhD | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is sealed. The issuer years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001540159.json (identity.jurisdiction)
- 10.4
- https://mcp.us-cm-kg.ai/events/NASDAQ/EDSA (the disclosure lines)
- 10.5
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.6
- https://www.sec.gov/Archives/edgar/data/1540159/000117184325007914/edsa20250930_10k.htm (the auditor)
- 10.7
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://www.edesabiotech.com/investors/analyst-coverage/ (coverage)
- 10.9
- https://mcp.us-cm-kg.ai/record/NASDAQ/EDSA (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US27966L3069"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:c93bd1071f8a6293.